|
OVERVIEW
OF THE FIQR
The original Fibromyalgia Impact Questionnaire (FIQ)
was developed in the late 1980s by Drs
Carol Burckhardt, Sharon Clark and
Robert Bennett at Oregon Health &
Science University in Portland, Oregon USA. At
that time the clinical features of
fibromyalgia were just being described,
and the FIQ was an attempt to
capture the total spectrum of problems
related to fibromyalgia and the
responses to therapy. The FIQ was first
published in 1991 and since that
time has been extensively used as an
index of disease activity and
therapeutic efficacy.
Its development is described in separate
reviews by
Dr. Burckhardt
and
Dr. Bennett.
The original FIQ
has
been used in some
300 research
publications, and has been translated
into
46 languages:
|
Afrikaans* |
English for S. Africa*
|
Icelandic |
Slovak* |
|
Arabic* |
English for the UK* |
Italian for Italy* |
Spanish for Argentina*
|
|
Bulgarian* |
Filipino* |
Korean* |
Spanish for Mexico* |
|
Catalan |
Finnish for Finland*
|
Mandarin for China* |
Spanish for Puerto Rico*
|
|
Croatian* |
French for Belgium* |
Norwegian for Norway*
|
Spanish for Spain* |
|
Czech* |
French for Canada* |
Polish for Poland* |
Spanish for the USA*
|
|
Danish for Denmark* |
French for France* |
Portuguese for Brazil*
|
Swedish for Sweden* |
|
Dutch for Belgium (Flemish)*
|
German for Austria* |
Portuguese for Portugal*
|
Turkish for Turkey |
|
Dutch for the Netherlands*
|
German for Germany* |
Romanian* |
Ukrainian* |
|
English for Canada* |
Greek* |
Russian for Israel* |
Moroccan |
|
English for Ireland |
Hebrew* |
Russian for Ukraine*
|
|
|
English for New Zealand
|
Hungarian* |
Serbian* |
|
Development of the FIQR
In 2009 Drs Robert Bennett and
Ron Friend and colleagues at OHSU
revised the original FIQ to
remedy
issues that
had become apparent over the years since
its introduction in 1991. The revised FIQ, now called the FIQR, has
replaced the original FIQ for routine
use in fibromyalgia related studies and
routine clinical use. This major
revision corrects the
problems
encountered in the original FIQ; and
eliminates the complex scoring of the
original FIQ. The FIQR has
been endorsed
by the leading authorities
in
fibromyalgia research.
A
separate version of the FIQR, the
SIQR (symptom
impact questionnaire), can be used for
comparing fibromyalgia patients to
patients with other diagnoses, as it
that omits the word fibromyalgia in the
questions. This has been used to
evaluate symptoms that characterize
rheumatoid arthritis (RA), lupus (SLE)
and fibromyalgia (FM).
The FIQR and SIQR can be
used as a paper versions or adapted to
on-line use. They both take about 2
minutes to complete, and hand scoring
takes approximately 1 minute.
Comparison of FIQR and
FIQ
The results of the total FIQR can be reasonably compared with the
results reported in older papers using the original FIQ, as is seen
in this
scatterplot of the total score for the FIQR and FIQ in 202 FM
subjects
(r=0.88, p<0.001).
Taken
from: Bennett
RM,
Friend R,
Jones KD,
Ward R,
Han BK,
Ross RL.
The
Revised Fibromyalgia Impact Questionnaire (FIQR): validation and
psychometric properties.
Arthritis Res Ther. 2009;11(4):R120
Use of the FIQR and SIQR
The FIQR and SIQR are licensed by
the
MAPI Research Trust
on behalf of the copyright holders
*Use of the FIQR and SIQR is
free for academic and clinical projects
|
